CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2012; 33(03): 182-184
DOI: 10.4103/0971-5851.103151
CASE REPORT

Congenital sacrococcygeal PNET and chemotherapy

Colin Patrick Hawkes
Department of Haematology/ Oncology, Our Lady′s Children′s Hospital, Crumlin, Dublin, Ireland
,
David R Betts
National Centre for Medical Genetics, Crumlin, Dublin, Ireland
,
John O′Brien
Department of Pathology, Our Lady′s Children′s Hospital, Crumlin, Dublin, Ireland
,
Maureen J O′Sullivan
Department of Pathology, Our Lady′s Children′s Hospital, Crumlin, Dublin, Ireland
,
Michael Capra
Department of Haematology/ Oncology, Our Lady′s Children′s Hospital, Crumlin, Dublin, Ireland
› Author Affiliations

Abstract

We present the case of a congenital localised sacrococcygeal primitive neuroectodermal tumor treated aggressively with surgical resection and modified age-appropriate adjuvant chemotherapy. The conventional combination chemotherapy of vincristine, adriamycin, cyclophosphamide, ifosfamide and etoposide was modified to a regimen including vincristine, adriamicin, cyclophosphamide and actinomycin in order to minimise the predicted toxicity in this age group. Adjuvant "induction" chemotherapy commenced at 4 weeks of age and consisted of four cycles of vincristine, adriamycin and cyclophosphamide at 50%, 75%, 75% and 100% of recommended doses (vincristine 0.05 mg/kg, adriamycin 0.83 mg/kg daily × 2, cyclophosphamide 40 mg/kg) at 3-weekly intervals. This was followed by four cycles of "maintenance" chemotherapy with vincristine (0.025 mg/kg), actinomycin (0.025 mg/kg) and cyclophosphamide (36 mg/kg) at full recommended doses. Cardioxane at a dose of 16.6 mg/kg was infused immediately prior to the adriamycin. Our patient is thriving at 19 months out from end of treatment.



Publication History

Article published online:
02 August 2021

© 2012. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Moore SW, Satge D, Sasco AJ, Zimmermann A, Plaschkes J. The epidemiology of neonatal tumours. Report of an international working group. Pediatr Surg Int 2003:19:509-19.
  • 2 Sebire NJ, Fowler D, Ramsay AD. Sacrococcygeal tumors in infancy and childhood; A retrospective histopathological review of 85 cases. Fetal Pediatr Pathol 2004:23:295-303.
  • 3 Lee AC, Wong YC, Fung SH, Kwong NS, Tsui KY, Ramsay AD. Congenital sacrococcygeal primitive neuroectodermal tumor. Med Pediatr Oncol 2000:34:448-50.
  • 4 Lemire RJ, Pendergrass TW, Beckwith JB, Ellenbogen RG. Tumors and malformations of the caudal spinal axis. Pediatr Neurosurg 2003:38:174-80.
  • 5 Dehner LP. Neoplasms of the fetus and neonate. Monogr Pathol 1981:286-345.
  • 6 Harms D, Schmidt D, Leuschner I. Abdominal, retroperitoneal and sacrococcygeal tumours of the newborn and the very young infant. Report from the kiel paediatric tumour registry. Eur J Pediatr 1989:148:720-8.
  • 7 Song JS, Kim IK, Kim YM, Khang SK, Kim KR, Lee Y. Extrarenal teratoid wilms′ tumor: Two cases in unusual locations, one associated with elevated serum afp. Pathol Int 2010:60:35-41.
  • 8 Sonmez K, Turkyilmaz Z, Karabulut R, Kapisiz A, Eser EP, Memiº L, et al . A triton tumor mimicking sacrococcygeal teratoma. J Pediatr Surg 2009:44: e5-8.
  • 9 Santi M, Bulas D, Fasano R, Ponsky T, Sandler A, Richter E, et al. Congenital ependymoblastoma arising in the sacrococcygeal soft tissue: A case study. Clin Neuropathol 2008:27:78-82.
  • 10 Murphy MN, Dhalla SS, Diocee M, Halliday W, Wiseman NE, deSa DJ. Congenital ependymoblastoma presenting as a sacrococcygeal mass in a newborn: An immunohistochemical, light and electron microscopic study. Clin Neuropathol 1987:6:169-73.
  • 11 Tanaka K, Kanai M, Yosizawa J, Yamazaki Y. A case of neonatal neuroblastoma mimicking altman type iii sacrococcygeal teratoma. J Pediatr Surg 2005:40:578-80.
  • 12 Meazza C, Ferrari A, Fumagalli M, Collini P, Casanova M, Pugni L, et al. A case of congenital peripheral primitive neuroectodermal tumor presenting with multiple metastases. J Pediatr Hematol Oncol 2008:30:36-8.
  • 13 Kim SY, Tsokos M, Helman LJ. Dilemmas associated with congenital ewing sarcoma family tumors. J Pediatr Hematol Oncol 2008:30:4-7.
  • 14 Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN, et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children′s oncology group study d9803. J Clin Oncol 2009:27:5182-8.